Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | ▲1 | Malignant Central Nervous System Neoplasm | +66.7 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606281 |
| 1 | = | Malignant Uterine Corpus Neoplasm | +66.7 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606282 |
| 3 | ▲2 | Malignant Kidney Neoplasm | +14.9 | 92.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606284 |
| 3 | ▲4 | Multiple Myeloma | +14.9 | 92.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606283 |
| 5 | ▲1 | Malignant Colon Neoplasm | +14.8 | 85.2 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606285 |
| 6 | ▲2 | Malignant Liver Neoplasm | +14.8 | 81.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606287 |
| 6 | ▲2 | Malignant Pancreatic Neoplasm | +14.8 | 81.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606286 |
| 6 | ▼3 | Malignant Vulvar Neoplasm | +14.8 | 81.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606288 |
| 9 | ▲1 | Non-Hodgkin Lymphoma | +11.1 | 70.4 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606289 |
| 10 | ▼6 | Malignant Vaginal Neoplasm | +7.4 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606290 |
| 11 | ▲5 | Malignant Lung Neoplasm | +3.7 | 63 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606291 |
| 11 | ▲4 | Malignant Ovarian Neoplasm | +3.7 | 63 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606292 |
| 13 | ▲1 | Malignant Rectal Neoplasm | +3.7 | 55.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606293 |
| 14 | ▼2 | Malignant Anal Neoplasm | 0 | 51.9 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606294 |
| 15 | ▼2 | Malignant Salivary Gland Neoplasm | -3.7 | 48.1 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606295 |
| 16 | ▲4 | Malignant Breast Neoplasm | -3.7 | 44.4 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606296 |
| 17 | = | Cutaneous Melanoma | -7.4 | 40.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606297 |
| 18 | ▼1 | Malignant Laryngeal Neoplasm | -7.4 | 37 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606298 |
| 19 | ▲2 | Leukemia | -11.1 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606299 |
| 20 | ▲4 | Malignant Esophageal Neoplasm | -11.2 | 29.6 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606300 |
| 21 | ▲1 | Malignant Mesothelioma | -14.8 | 25.9 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606301 |
| 22 | ▼5 | Malignant Hypopharyngeal Neoplasm | -14.8 | 22.2 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606302 |
| 23 | = | Malignant Nasopharyngeal Neoplasm | -18.5 | 18.5 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606303 |
| 24 | ▲4 | Malignant Bladder Neoplasm | -18.5 | 14.8 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606304 |
| 25 | ▲4 | Hodgkin Lymphoma | -25.9 | 11.1 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606305 |
| 26 | ▲8 | Malignant Thyroid Gland Neoplasm | -29.7 | 7.4 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606306 |
| 27 | ▲6 | Malignant Cervical Neoplasm | -37.1 | 3.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606307 |
| 28 | ▲7 | Malignant Gastric Neoplasm | -48.2 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2606308 |
Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 0ad367faf3570a439dc69167